Yong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yong Wang has a total of 159 co-authors. Here are the top co-authors by number of shared publications:
Lidya Abune
Department of Biomedical Engineering Pennsylvania State University University Park PA 16802 USA
15 shared publicationsNan Zhao
Department of Biomedical Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802, United States
15 shared publicationsBrandon Davis
Department of Biomedical Engineering, The Pennsylvania State University, University Park, USA
14 shared publicationsKyungsene Lee
Department of Biomedical Engineering, The Pennsylvania State University, University Park, USA
14 shared publicationsXuelin Wang
Department of Biomedical Engineering, The Pennsylvania State University, University Park, USA
14 shared publicationsConnie Wen
Department of Biomedical Engineering, The Pennsylvania State University, University Park, USA
13 shared publications
Latest Publications
- 14 August 2026
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-15
Biomimetic zona pellucida-encapsulated islets for sustained glycaemic control in immunocompetent mice
Islet transplantation is a promising therapy for treating type 1 diabetes. Thin capsules, although offering numerous advantages over thicker ones in islet transplantation, pose persistent challenges for ensuring long-term cell protection. Here we show a biomimetic approach for cell protection using thin capsules, inspired by the biological development of the zona pellucida. A thin 20-μm hydrogel capsule is spontaneously generated on the cell surface with 100% encapsulation efficiency through aptamer-directed molecular recognition, crosslinking and hardening. The entire encapsulation process takes place droplet-free and stress-free under physiological conditions, without exposure to harsh factors or any loss of cellular viability or function. Immunocompetent diabetic mice receiving encapsulated allogeneic islets achieved normoglycaemia, with most sustaining it for more than 100 days.
- 14 August 2026
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-15
Biomimetic zona pellucida-encapsulated islets for sustained glycaemic control in immunocompetent mice
Islet transplantation is a promising therapy for treating type 1 diabetes. Thin capsules, although offering numerous advantages over thicker ones in islet transplantation, pose persistent challenges for ensuring long-term cell protection. Here we show a biomimetic approach for cell protection using thin capsules, inspired by the biological development of the zona pellucida. A thin 20-μm hydrogel capsule is spontaneously generated on the cell surface with 100% encapsulation efficiency through aptamer-directed molecular recognition, crosslinking and hardening. The entire encapsulation process takes place droplet-free and stress-free under physiological conditions, without exposure to harsh factors or any loss of cellular viability or function. Immunocompetent diabetic mice receiving encapsulated allogeneic islets achieved normoglycaemia, with most sustaining it for more than 100 days.
- Open Access
- 11 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (17) , 8184-8195
Directed Molecular Assembly and Crosslinking for Conformal Coating of Mesenchymal Stem Cells Using a Bispecific DNA-Enzyme Conjugate
Current cell encapsulation methods face problems with large encapsulation volumes. In this study, we present a modular cell-surface conformal coating strategy using a bispecific DNA-enzyme conjugate to direct molecular assembly and crosslinking. The bispecific conjugate exhibited sustained retention on the cell membrane with a half-life on the order of hours. The conjugate catalyzed the formation of a 10 to 20 μm thick fibrin layer upon addition of fibrinogen, allowing the adsorption and deposition of alginate and poly-L-lysine crosslink the coating. The platform was compatible with spheroids spanning ∼200 μm to 1 mm in diameter while maintaining uniform surface coverage. The coating efficiency was 100%, with no empty capsules observed. Encapsulation improved structural stability of spheroids in extracellular matrix culture, preventing spheroid spreading and immune attack while preserving morphology over extended incubation. Encapsulated spheroids maintained high viability and secreted a range of angiogenic factors. These factors enhanced endothelial cell viability, promoted tube formation, and increased cell migration. Therefore, this study successfully demonstrates a strategy for conformal cell coating by displaying a bispecific DNA-enzyme conjugate on the cell surface.
- 11 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (17) , 8184-8195
Open AccessDirected Molecular Assembly and Crosslinking for Conformal Coating of Mesenchymal Stem Cells Using a Bispecific DNA-Enzyme Conjugate
Current cell encapsulation methods face problems with large encapsulation volumes. In this study, we present a modular cell-surface conformal coating strategy using a bispecific DNA-enzyme conjugate to direct molecular assembly and crosslinking. The bispecific conjugate exhibited sustained retention on the cell membrane with a half-life on the order of hours. The conjugate catalyzed the formation of a 10 to 20 μm thick fibrin layer upon addition of fibrinogen, allowing the adsorption and deposition of alginate and poly-L-lysine crosslink the coating. The platform was compatible with spheroids spanning ∼200 μm to 1 mm in diameter while maintaining uniform surface coverage. The coating efficiency was 100%, with no empty capsules observed. Encapsulation improved structural stability of spheroids in extracellular matrix culture, preventing spheroid spreading and immune attack while preserving morphology over extended incubation. Encapsulated spheroids maintained high viability and secreted a range of angiogenic factors. These factors enhanced endothelial cell viability, promoted tube formation, and increased cell migration. Therefore, this study successfully demonstrates a strategy for conformal cell coating by displaying a bispecific DNA-enzyme conjugate on the cell surface.
- Open Access
- 12 December 2025
- Published by IOP Publishing in Biofabrication
- Vol. 18 (1) , 015013
Collagen hydrogel tube microbioreactors for cell and tissue manufacturing
The large-scale production of mammalian cells, particularly stem cells for clinical applications, remains challenging with existing cell culture technologies such as two-dimensional cell culture flasks or three-dimensional stirred tank bioreactors. Current methods have issues such as excessive cell aggregation and significant shear stress-induced cell death, resulting in low cell yield, unacceptable batch-to-batch variation, high production costs, and difficulties in scaling up. We hypothesize that creating a cell-friendly microenvironment that has efficient mass transport and minimized shear stress can enhance cell culture efficiency. In this study, we developed a novel hydrogel tube microbioreactor using collagen proteins (ColTubes) to test this hypothesis. First, we designed an innovative micro-extruder for fabricating ColTubes loaded with cells. Our results show that collagen proteins form a dense and robust nanofiber network capable of shielding cells from hydrodynamic stress while maintaining cell mass below 400 µ m in diameter. The tube shell contains abundant nanopores that allow the cell culture medium to permeate and nourish the cells. Additionally, the collagen fibers serve as a substrate for cell adhesion. We show that ColTubes support high cell viability, rapid expansion, and impressive volumetric yields, offering substantial improvements over current methods. To our knowledge, ColTubes is a novel approach that has not been previously reported for cell manufacturing. ColTubes represents a scalable, cost-effective, and efficient solution for large-scale cell production.
- 12 December 2025
- Published by IOP Publishing in Biofabrication
- Vol. 18 (1) , 015013
Open AccessCollagen hydrogel tube microbioreactors for cell and tissue manufacturing
The large-scale production of mammalian cells, particularly stem cells for clinical applications, remains challenging with existing cell culture technologies such as two-dimensional cell culture flasks or three-dimensional stirred tank bioreactors. Current methods have issues such as excessive cell aggregation and significant shear stress-induced cell death, resulting in low cell yield, unacceptable batch-to-batch variation, high production costs, and difficulties in scaling up. We hypothesize that creating a cell-friendly microenvironment that has efficient mass transport and minimized shear stress can enhance cell culture efficiency. In this study, we developed a novel hydrogel tube microbioreactor using collagen proteins (ColTubes) to test this hypothesis. First, we designed an innovative micro-extruder for fabricating ColTubes loaded with cells. Our results show that collagen proteins form a dense and robust nanofiber network capable of shielding cells from hydrodynamic stress while maintaining cell mass below 400 µ m in diameter. The tube shell contains abundant nanopores that allow the cell culture medium to permeate and nourish the cells. Additionally, the collagen fibers serve as a substrate for cell adhesion. We show that ColTubes support high cell viability, rapid expansion, and impressive volumetric yields, offering substantial improvements over current methods. To our knowledge, ColTubes is a novel approach that has not been previously reported for cell manufacturing. ColTubes represents a scalable, cost-effective, and efficient solution for large-scale cell production.
- 25 September 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 387, 114251
Enhanced safety and potency in local angiogenic growth factor delivery via aptamer functionalization of hydrogels
- 25 September 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 387, 114251
Enhanced safety and potency in local angiogenic growth factor delivery via aptamer functionalization of hydrogels
- Open Access
- 16 June 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale Horizons
- Vol. 10 (8) , 1703-1716
DNA-triggered activation of aptamer-neutralized enzyme for in situ formation of injectable hydrogel
Injectable hydrogels have been widely studied for the embolization of vascular malformations and the control of bleeding in hemorrhages. An ideal injectable hydrogel in these applications needs to form once contacting with the blood components, which enables easy control of hydrogel formation and injectability. However, this type of injectable hydrogel has not yet been widely studied. In this work, an injectable hydrogel system was developed by using a bispecific aptamer-neutralized enzyme and a triggering DNA. The results show that the system remained in its solution or pre-gelation state in the presence of the bispecific aptamer. Upon contact with the triggering DNA, the system was transformed into a hydrogel state. In vitro aneurysm and endovascular embolization were further conducted, and the results showed the DNA administered out of the hydrogel system could trigger the activation of aptamer-bound enzymes for the accelerated formation of the injectable hydrogel. Therefore, this study has successfully demonstrated that a bispecific aptamer-neutralized enzyme in the pre-gelation system can be rapidly released to accelerate the formation of injectable hydrogels when the system is in contact with the blood that contains a triggering DNA.
- 16 June 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale Horizons
- Vol. 10 (8) , 1703-1716
Open AccessDNA-triggered activation of aptamer-neutralized enzyme for in situ formation of injectable hydrogel
Injectable hydrogels have been widely studied for the embolization of vascular malformations and the control of bleeding in hemorrhages. An ideal injectable hydrogel in these applications needs to form once contacting with the blood components, which enables easy control of hydrogel formation and injectability. However, this type of injectable hydrogel has not yet been widely studied. In this work, an injectable hydrogel system was developed by using a bispecific aptamer-neutralized enzyme and a triggering DNA. The results show that the system remained in its solution or pre-gelation state in the presence of the bispecific aptamer. Upon contact with the triggering DNA, the system was transformed into a hydrogel state. In vitro aneurysm and endovascular embolization were further conducted, and the results showed the DNA administered out of the hydrogel system could trigger the activation of aptamer-bound enzymes for the accelerated formation of the injectable hydrogel. Therefore, this study has successfully demonstrated that a bispecific aptamer-neutralized enzyme in the pre-gelation system can be rapidly released to accelerate the formation of injectable hydrogels when the system is in contact with the blood that contains a triggering DNA.
- Open Access
- 28 May 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (6) , 780
Current Modalities in Soft-Tissue Reconstruction and Vascularized Adipose Engineering
Soft-tissue loss resulting from trauma or oncologic resection is a significant problem worldwide. Surgical reconstruction using adipose tissue has long been the gold-standard solution. However, these surgeries are often highly morbid, not always feasible in patients with insufficient adipose, and can have unpredictable results. Engineered soft-tissue replacements present a promising alternative. Many cell types, such as adipose-derived stem cells, have been recognized as a viable starting platform upon which new avenues in tissue engineering can be built. Additionally, efforts to develop scaffolds that can mimic the native extracellular matrix have been made with varying success. However, the suboptimal vascularization of engineered replacements is still a major limiting factor for achieving clinical translation. The current research explores the integration of all these techniques, including the use of growth factors, bioactive molecules, and advanced microsurgical techniques to enhance the vascularization process. This translational review covers the clinically standard methods of soft-tissue reconstruction and dives into emerging engineering techniques to develop vascularized adipose alternatives.
- 28 May 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (6) , 780
Open AccessCurrent Modalities in Soft-Tissue Reconstruction and Vascularized Adipose Engineering
Soft-tissue loss resulting from trauma or oncologic resection is a significant problem worldwide. Surgical reconstruction using adipose tissue has long been the gold-standard solution. However, these surgeries are often highly morbid, not always feasible in patients with insufficient adipose, and can have unpredictable results. Engineered soft-tissue replacements present a promising alternative. Many cell types, such as adipose-derived stem cells, have been recognized as a viable starting platform upon which new avenues in tissue engineering can be built. Additionally, efforts to develop scaffolds that can mimic the native extracellular matrix have been made with varying success. However, the suboptimal vascularization of engineered replacements is still a major limiting factor for achieving clinical translation. The current research explores the integration of all these techniques, including the use of growth factors, bioactive molecules, and advanced microsurgical techniques to enhance the vascularization process. This translational review covers the clinically standard methods of soft-tissue reconstruction and dives into emerging engineering techniques to develop vascularized adipose alternatives.
- Open Access
- 20 May 2025
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 17 (3) , e70016
Islet Transplantation: Microencapsulation, Nanoencapsulation, and Hypoimmune Engineering
Islet transplantation represents a promising curative approach for type 1 diabetes by restoring glucose‐responsive insulin secretion. However, the requirement for lifelong immunosuppression to prevent immune rejection can lead to significant side effects. Emerging strategies such as microencapsulation, nanoencapsulation, and hypoimmune engineering are being developed to protect transplanted islets from immune attack, thereby enhancing their viability and function. This review critically examines these innovative technologies, highlighting the methodologies, materials, experimental and clinical outcomes, as well as the challenges they face and potential solutions to overcome those challenges.
- 20 May 2025
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 17 (3) , e70016
Open AccessIslet Transplantation: Microencapsulation, Nanoencapsulation, and Hypoimmune Engineering
Islet transplantation represents a promising curative approach for type 1 diabetes by restoring glucose‐responsive insulin secretion. However, the requirement for lifelong immunosuppression to prevent immune rejection can lead to significant side effects. Emerging strategies such as microencapsulation, nanoencapsulation, and hypoimmune engineering are being developed to protect transplanted islets from immune attack, thereby enhancing their viability and function. This review critically examines these innovative technologies, highlighting the methodologies, materials, experimental and clinical outcomes, as well as the challenges they face and potential solutions to overcome those challenges.
- 6 December 2024
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 40 (50) , 26751-26759
Bidirectional Enzyme Inhibition and Activation for In Situ Formation of Injectable Hydrogel Using a Bispecific Aptamer
In situ injectable hydrogels have been explored for biomedical applications, including regenerative medicine and drug delivery. However, controlling the kinetics of their gelation to facilitate easy injection remains a challenge. The purpose of this study was to demonstrate the potential of using bispecific aptamers and complementary sequences as a bidirectional modulation system for controlling enzyme-mediated hydrogel formation kinetics. The results show that a bispecific thrombin-binding aptamer effectively inhibits thrombin activity and significantly slowed fibrin hydrogel formation. Upon interaction with its complementary sequence, this inhibition could be reversed. As a result, the aptamer-bound thrombin was activated, leading to an acceleration of the fibrin formation kinetics. Thus, bispecific aptamers and complementary sequences can effectively function as dynamic control systems for enzyme-catalyzed in situ injectable hydrogel formation.
- 6 December 2024
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 40 (50) , 26751-26759
Bidirectional Enzyme Inhibition and Activation for In Situ Formation of Injectable Hydrogel Using a Bispecific Aptamer
In situ injectable hydrogels have been explored for biomedical applications, including regenerative medicine and drug delivery. However, controlling the kinetics of their gelation to facilitate easy injection remains a challenge. The purpose of this study was to demonstrate the potential of using bispecific aptamers and complementary sequences as a bidirectional modulation system for controlling enzyme-mediated hydrogel formation kinetics. The results show that a bispecific thrombin-binding aptamer effectively inhibits thrombin activity and significantly slowed fibrin hydrogel formation. Upon interaction with its complementary sequence, this inhibition could be reversed. As a result, the aptamer-bound thrombin was activated, leading to an acceleration of the fibrin formation kinetics. Thus, bispecific aptamers and complementary sequences can effectively function as dynamic control systems for enzyme-catalyzed in situ injectable hydrogel formation.
- 16 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (43) , 58346-58356
Cardiac Matrix-Derived Granular Hydrogel Enhances Cell Function in 3D Culture
Hydrogels derived from decellularized porcine myocardial matrix have demonstrated significant potential as therapeutic delivery platforms for promoting cardiac repair after injury. Our previous study developed a fibrin-enriched cardiac matrix hydrogel to enhance its angiogenic capacities. However, the bulk hydrogel structure may limit their full potential in cell delivery. Recently, granular hydrogels have emerged as a promising class of biomaterials, offering unique features such as a highly interconnected porous structure that facilitates nutrient diffusion and enhances cell viability. Several techniques have been developed for fabricating various types of granular hydrogels, among which extrusion fragmentation is particularly appealing due to its adaptability to many types of hydrogels, low cost, and high scalability. In this study, we first confirmed the effects of the bulk cardiac matrix hydrogel on the viability of encapsulated human umbilical vein endothelial cells and human mesenchymal stem cells. We then tested the feasibility of producing granular hydrogels from both cardiac matrix and fibrin-enriched cardiac matrix through cellular cross-linking of microgels fabricated by extrusion fragmentation. Afterward, we examined the roles of the produced granular hydrogels in the embedded cells and cell spheroids. Our in vitro data demonstrate that cardiac matrix-derived granular hydrogels support optimal viability of encapsulated cells and promote sprouting of human mesenchymal stem cell spheroids. Additionally, granular hydrogel derived from fibrin-enriched cardiac matrix accelerates angiogenic sprouting of embedded human mesenchymal stem cell spheroids. The results obtained from this study lay an important foundation for the future exploration of using cardiac matrix-derived granular hydrogels for cardiac cell therapy.
- 16 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (43) , 58346-58356
Cardiac Matrix-Derived Granular Hydrogel Enhances Cell Function in 3D Culture
Hydrogels derived from decellularized porcine myocardial matrix have demonstrated significant potential as therapeutic delivery platforms for promoting cardiac repair after injury. Our previous study developed a fibrin-enriched cardiac matrix hydrogel to enhance its angiogenic capacities. However, the bulk hydrogel structure may limit their full potential in cell delivery. Recently, granular hydrogels have emerged as a promising class of biomaterials, offering unique features such as a highly interconnected porous structure that facilitates nutrient diffusion and enhances cell viability. Several techniques have been developed for fabricating various types of granular hydrogels, among which extrusion fragmentation is particularly appealing due to its adaptability to many types of hydrogels, low cost, and high scalability. In this study, we first confirmed the effects of the bulk cardiac matrix hydrogel on the viability of encapsulated human umbilical vein endothelial cells and human mesenchymal stem cells. We then tested the feasibility of producing granular hydrogels from both cardiac matrix and fibrin-enriched cardiac matrix through cellular cross-linking of microgels fabricated by extrusion fragmentation. Afterward, we examined the roles of the produced granular hydrogels in the embedded cells and cell spheroids. Our in vitro data demonstrate that cardiac matrix-derived granular hydrogels support optimal viability of encapsulated cells and promote sprouting of human mesenchymal stem cell spheroids. Additionally, granular hydrogel derived from fibrin-enriched cardiac matrix accelerates angiogenic sprouting of embedded human mesenchymal stem cell spheroids. The results obtained from this study lay an important foundation for the future exploration of using cardiac matrix-derived granular hydrogels for cardiac cell therapy.
- 28 December 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (1) , 868-877
Biomimetic Bacterial Capsule for Enhanced Aptamer Display and Cell Recognition
Great effort has been made to encapsulate or coat living mammalian cells for a variety of applications ranging from diabetes treatment to three-dimensional printing. However, no study has reported the synthesis of a biomimetic bacterial capsule to display high-affinity aptamers on the cell surface for enhanced cell recognition. Therefore, we synthesized an ultrathin alginate-polylysine coating to display aptamers on the surface of living cells with natural killer (NK) cells as a model. The results show that this coating-mediated aptamer display is more stable than direct cholesterol insertion into the lipid bilayer. The half-life of the aptamer on the cell surface can be increased from less than 1.5 to over 20 h. NK cells coated with the biomimetic bacterial capsule exhibit a high efficiency in recognizing and killing target cells. Therefore, this work has demonstrated a promising cell coating method for the display of aptamers for enhanced cell recognition.
- 28 December 2023
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (1) , 868-877
Biomimetic Bacterial Capsule for Enhanced Aptamer Display and Cell Recognition
Great effort has been made to encapsulate or coat living mammalian cells for a variety of applications ranging from diabetes treatment to three-dimensional printing. However, no study has reported the synthesis of a biomimetic bacterial capsule to display high-affinity aptamers on the cell surface for enhanced cell recognition. Therefore, we synthesized an ultrathin alginate-polylysine coating to display aptamers on the surface of living cells with natural killer (NK) cells as a model. The results show that this coating-mediated aptamer display is more stable than direct cholesterol insertion into the lipid bilayer. The half-life of the aptamer on the cell surface can be increased from less than 1.5 to over 20 h. NK cells coated with the biomimetic bacterial capsule exhibit a high efficiency in recognizing and killing target cells. Therefore, this work has demonstrated a promising cell coating method for the display of aptamers for enhanced cell recognition.